Computer Aided Detection

Computer Aided Detection (CAD) - US and European Market Report

Global Industry Analysts, Date of Publication: Feb 25, 2015, 115 Pages
US$4,950.00
GIA-MCP6036

Computer Aided Detection Industry Report

This report analyzes the US and European markets for Computer Aided Detection (CAD) in US$ Thousands by the following Application Segments - Breast, Chest, and Others. The US market is also analysed in Number of Units for the above Application Segments. The report also provides a consolidated, single-segment volume analysis for the European market. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 29 companies including many key and niche players such as -

EDDA Technology, Inc.
Hologic, Inc.
iCAD, Inc.
Invivo Corp.
Merge Healthcare, Inc.


TABLE OF CONTENTS

 I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

      Study Reliability and Reporting Limitations                       I-1
      Disclaimers                                                       I-2
      Data Interpretation & Reporting Level                             I-2
       Quantitative Techniques & Analytics                              I-3
      Product Definitions and Scope of Study                            I-3


 II. A US AND EUROPEAN MARKET REPORT

  1. OUTLOOK                                                            II-1
      Computer Aided Detection - Offering “Second Look” for
       Radiology Analysis                                               II-1
      The Need for Early Disease Diagnosis and the Role of CAD          II-1
       Table 1: Global Aging Population by Age Group: 1975-2050
       (includes corresponding Graph/Chart)                             II-2
       Market Highlights                                                II-3
      Major Drivers & Restraints                                        II-3
      Breast CAD to Hold its Forte in the CAD Market                    II-4
      Recession in Retrospect and the Road Ahead                        II-5
      Improving Healthcare Expenditure to Foster Growth                 II-5
       Table 2: Per-Capita Healthcare Expenditure in US$ for Select
       Regions: 2014 (includes corresponding Graph/Chart)               II-6

       Table 3: Healthcare Spending as a Percentage of GDP in Select
       Developing Countries (2014E) (includes corresponding
       Graph/Chart)                                                     II-6

       Table 4: Healthcare Spending as a Percentage of GDP in Select
       Developed Countries for 2004, 2008 & 2014E (includes
       corresponding Graph/Chart)                                       II-6

       Table 5: Top 20 Countries with the Highest Healthcare
       Spending as a Percentage of GDP: 2014E (includes
       corresponding Graph/Chart)                                       II-7

  2. MARKET OVERVIEW & TRENDS                                           II-8
      From “Second Reader” to “First Reader” Use - the Unconquered
       Avenue of CAD Systems                                            II-8
      CAD Use Rises despite Controversies                               II-8
      Replacements to Fuel Market Growth                                II-9
      High Dependence on Related Modality Continues                     II-9
      Market Calls for Higher Efficiencies in CAD                       II-9
      Product Developments Underway to Expand Utility                   II-9
      Information Provision - A Key Feature under Development for
       Enhanced Efficiency                                              II-10
      Research finds Interactive Use of CAD More Efficient              II-11
      Rising Incidence of Cancer - A Major Market Driver                II-11
       Cancer Prone Sites based on Age                                  II-11
       World Cancer Statistics - Incidence and Mortality Data           II-12
        Table 6: World Cancer Incidence by Geographic Region and
        Gender (2012): Number of New Cancer Cases Reported in
        Thousands for Asia-Oceania, Europe, North America, Latin
        America & the Caribbean, and Africa (includes corresponding
        Graph/Chart)                                                    II-12

        Table 7: World Cancer Mortality by Geographic Region and
        Gender (2012): Number of Cancer- Related Deaths in Thousands
        for Asia-Oceania, Europe, North America, Latin America & the
        Caribbean, and Africa (includes corresponding Graph/Chart)      II-13

        Table 8: Global Incidence of Common Cancers in Men (2012):
        Number of New Cases Reported in Thousands for Lung &
        Bronchus, Prostate, Colorectal and Liver Cancers (includes
        corresponding Graph/Chart)                                      II-13

        Table 9: Global Incidence of Common Cancers in Women (2012):
        Number of New Cases Reported in Thousands for Breast,
        Colorectal, Lung & Bronchus and Liver Cancers (includes
        corresponding Graph/Chart)                                      II-14

        Table 10: Global Cancer Mortality in Men for Select Cancers
        (2012): Number of Deaths in Thousands for Lung & Bronchus,
        Liver, Colorectal and Prostate Cancers (includes
        corresponding Graph/Chart)                                      II-14

        Table 11: Global Cancer Mortality in Women for Select
        Cancers (2012): Number of Deaths in Thousands for Breast,
        Lung & Bronchus, Colorectal and Liver (includes
        corresponding Graph/Chart)                                      II-14

        Table 12: World Breast Cancer Statistics (2012): Top 20
        Countries with Highest Breast Cancer Rates (includes
        corresponding Graph/Chart)                                      II-15

  3. COMPETITION                                                        II-16
      iCAD - A Leading Independent Player in the Mammography CAD
       Segment                                                          II-16

  4. APPLICATIONS OF CAD                                                II-17
      Present Applications of CAD                                       II-17
      What Lies Ahead at the Application Front?                         II-17
      CAD in Breast Cancer                                              II-17
       CAD Simplifies Breast MRI Image Analysis; Tremendous Scope
        for Adoption Ahead                                              II-17
       Breast MRI - Lagging behind Mammography in Cancer Detection      II-18
       CAD Solutions for Breast Cancer                                  II-18
        SecondLook Digital (iCAD)                                       II-18
        R2 ImageChecker (Hologic, Inc.)                                 II-18
        SpectraLook CAD Solution (iCAD)                                 II-18
        DynaCAD Breast (Invivo)                                         II-19
        CADstream Breast MRI Application (Merge Healthcare)             II-19
         List of Select Approved CAD Solutions for Breast MRI           II-19
      CAD in Prostate Cancer                                            II-19
      CAD in Lung Cancer                                                II-20
       The Background                                                   II-20
       An Overview of CAD Solutions for Lung Cancer Detection           II-21
        IQQA (EDDA Technology)                                          II-21
        ClearRead +Detect™ (formerly OnGuard) (Riverain Technologies)   II-21
        xLNA (Philips)                                                  II-21
        syngo CAD Solutions (Siemens)                                   II-22
      CAD in Liver Cancer                                               II-22
       CAD Solutions for Liver Cancer Detection                         II-22
        CADstream (Merge Healthcare)                                    II-22
        IQQA (EDDA Technology)                                          II-22
      CAD in the Detection of Prostate Cancer                           II-22
       Available CAD Solutions for Prostate Cancer                      II-23
      CAD in the Detection of Colon Cancer                              II-23
      CAD in Cardiology                                                 II-24
       Increasing Need for CAD in Cardiology                            II-24
        Table 13: Cardiovascular Disease Incidence in the US by
        Gender & Age Group (per 1,000 Adults) (includes
        corresponding Graph/Chart)                                      II-24
       Automatic Workflow Integration Fuels Demand for Cardiac CAD      II-24
       Significant Hurdles Exist for CAD in Cardiology                  II-25

  5. REGIONAL PERSPECTIVE                                               II-26

  5a. THE UNITED STATES                                                 II-26
      A.Market Analysis                                                 II-26
        Current & Future Analysis                                       II-26
        Challenges in Evaluation Dents Approvals of New CAD Systems     II-26
        Final Guidance Documents on CAD offers Respite to Industry
         Players                                                        II-27
         CAD Devices, as Defined by the FDA                             II-27
         Guidance on 510(k) Application                                 II-28
         FDA’s FFDM Reclassification to Benefit CAD Market              II-28
        Competition                                                     II-28
         Table 14: The US Mammography CAD Market by Leading Player:
         2014 (includes corresponding Graph/Chart)                      II-28
         Select FDA Approved CAD Software: 2001-2013                    II-29
        Ageing Demographics: A Key Market Driver                        II-29
         Table 15: North American Elderly Population by Age Group:
         1975-2050 (includes corresponding Graph/Chart)                 II-30
        Rising Cancer Incidence, and the Need for Early Detection
         Propel Market Growth                                           II-30
         Table 16: New Cancer Cases in the US by State: 2014            II-31

         Table 17: New Cancer Cases in the US by Gender and Affected
         Site: 2014                                                     II-33

         Table 18: Cancer Related Deaths in the US by Gender and
         Body Site: 2014                                                II-35

         Table 19: Cancer Mortality in the US by Site for Male and
         Female Populations (2013): Breakdown of Number of Deaths
         for Breast, Lung & Bronchus, Colon & Rectum, Liver & Bile
         Duct, Prostate and Other Cancers (includes corresponding
         Graph/Chart)                                                   II-37
        CAD to Gain from Rapid Growth in CTC Volumes                    II-37
        Physicians’ Reluctance to Follow USPSTF - A Shot in the Arm
         for CAD Manufacturers                                          II-38
        Mammography and Breast MRI, and CAD Reimbursement in the US     II-38
         CMS Coverage for Screening and Diagnostic Mammography and
          Breast MRI - A Review                                         II-38
          Table 20: Medicare Reimbursement Codes and Allowable Rates
          for CAD in Mammography: 2012-2014                             II-39
         Low and Spotty Reimbursement Mars CAD in Prostate Cancer
          Detection                                                     II-39
         No Separate Codes for CAD in Prostate MRI                      II-39
      B.Market Analytics                                                II-40
        Value Analytics                                                 II-40
         Table 21: The US Recent Past, Current & Future Analysis for
         Computer Aided Detection (CAD) by Application - Breast,
         Chest and Other CAD Markets Independently Analyzed with
         Annual Sales Figures in US$ Thousand for Years 2013 through
         2020 (includes corresponding Graph/Chart)                      II-40

         Table 22: The US Historic Review for Computer Aided
         Detection (CAD) by Application - Breast, Chest and Other
         CAD Markets Independently Analyzed with Annual Sales
         Figures in US$ Thousand for Years 2007 through 2012
         (includes corresponding Graph/Chart)                           II-41

         Table 23: The US 14-Year Perspective for Computer Aided
         Detection (CAD) by Application - Percentage Breakdown of
         Dollar Sales for Breast, Chest and Other CAD Markets for
         Years 2007, 2014 and 2020 (includes corresponding
         Graph/Chart)                                                   II-42
        Volume Analytics                                                II-43
         Table 24: The US Recent Past, Current & Future Analysis for
         Computer Aided Detection (CAD) by Application - Breast,
         Chest and Other CAD Markets Independently Analyzed with
         Annual Sales Figures in Units for Years 2013 through 2020
         (includes corresponding Graph/Chart)                           II-43

         Table 25: The US Historic Review for Computer Aided
         Detection (CAD) by Application - Breast, Chest and Other
         CAD Markets Independently Analyzed with Annual Sales
         Figures in Units for Years 2007 through 2012 (includes
         corresponding Graph/Chart)                                     II-44

         Table 26: The US 14-Year Perspective for Computer Aided
         Detection (CAD) by Application - Percentage Breakdown of
         Unit Sales for Breast, Chest and Other CAD Markets for
         Years 2007, 2014 and 2020 (includes corresponding
         Graph/Chart)                                                   II-45

  5b. EUROPE                                                            II-46
      A.Market Analysis                                                 II-46
        Economic Woes Dampen European CAD Market Prospects              II-46
        Long-Term Prospects Appear Brighter                             II-46
        Breast CAD Dominates, Other Applications to Witness Fastest
         Growth                                                         II-46
        Rising Incidence of Cancer                                      II-47
         Table 27: European Cancer Incidence by Geographic Region
         (2012): Number of New Cancer Cases Reported in Thousands
         for Western Europe, Northern Europe, Southern Europe, and
         Central & Eastern Europe (includes corresponding
         Graph/Chart)                                                   II-48

         Table 28: Cancer Incidence in Western Europe by Site
         (2012): Number of New Cancer Cases Reported in Thousands
         for Prostate, Breast, Colorectal, Lung and Other Cancers
         (includes corresponding Graph/Chart)                           II-48

         Table 29: Cancer Incidence in Northern Europe by Site
         (2012): Number of New Cancer Cases Reported in Thousands
         for Breast, Prostate, Colorectal, Lung and Other Cancers
         (includes corresponding Graph/Chart)                           II-49

         Table 30: Cancer Incidence in Southern Europe by Site
         (2012): Number of New Cancer Cases Reported in Thousands
         for Colorectal, Breast, Lung, Prostate and Other Cancers
         (includes corresponding Graph/Chart)                           II-49

         Table 31: Cancer Incidence in Central and Eastern Europe by
         Site (2012): Number of New Cancer Cases Reported in
         Thousands for Lung, Colorectal, Breast, Stomach and Other
         Cancers (includes corresponding Graph/Chart)                   II-49
        Ageing Population Boosts Demand for Computer Aided Detection    II-50
         Table 32: European Country-wise Statistics of 60+
         Population as % of Total Population: 2013 (includes
         corresponding Graph/Chart)                                     II-50
      B.Market Analytics                                                II-51
        Value Analytics                                                 II-51
         Table 33: European Recent Past, Current & Future Analysis
         for Computer Aided Detection (CAD) by Application - Breast,
         Chest and Other CAD Markets Independently Analyzed with
         Annual Sales Figures in US$ Thousand for Years 2013 through
         2020 (includes corresponding Graph/Chart)                      II-51

         Table 34: European Historic Review for Computer Aided
         Detection (CAD) by Application - Breast, Chest and Other
         CAD Markets Independently Analyzed with Annual Sales
         Figures in US$ Thousand for Years 2007 through 2012
         (includes corresponding Graph/Chart)                           II-52

         Table 35: European 14-Year Perspective for Computer Aided
         Detection (CAD) by Application - Percentage Breakdown of
         Dollar Sales for Breast, Chest and Other CAD Markets for
         Years 2007, 2014 and 2020 (includes corresponding
         Graph/Chart)                                                   II-53
        Volume Analytics                                                II-54
         Table 36: European Recent Past, Current & Future Analysis
         for Computer Aided Detection (CAD) Market Analyzed with
         Annual Sales Figures in Units for Years 2013 through 2020
         (includes corresponding Graph/Chart)                           II-54

         Table 37: European Historic Review for Computer Aided
         Detection (CAD) Market Analyzed with Annual Sales Figures
         in Units for Years 2007 through 2012 (includes
         corresponding Graph/Chart)                                     II-55

  6. PRODUCT OVERVIEW                                                   II-56
      CAD - An Introduction                                             II-56
      A Brief History of CAD                                            II-56
      Methodology                                                       II-56
      Sensitivity / Specificity                                         II-57
      Absolute Detection Rate                                           II-57
      Applications of Computer-Aided Detection                          II-57
       Breast Cancer                                                    II-57
       Lung Cancer (Bronchial Carcinoma)                                II-57
      Evolution of Computer-Aided Detection for Mammography             II-58
      CAD Technology - Working Operation                                II-58
      Existing Limitations of CAD                                       II-59

  7. PRODUCT INNOVATIONS/INTRODUCTIONS                                  II-60
      VuCOMP Obtains Market Clearance for M-Vu® CAD and M-Vu Breast
       Density in Turkey                                                II-60
      VuCOMP Receives US FDA Approval for M-Vu CAD for Mammography
       Version 3.1                                                      II-60
      iCAD Obtains FDA Clearance for Mammography CAD Platform           II-60
      VuCOMP Receives Premarket Approval from FDA for M-Vu Film
       Mammography CAD                                                  II-60
      iCAD Introduces Advanced Mammography CAD System                   II-60
      Parascript Unveils Updated AccuDetect CAD Technology              II-60

  8. RECENT INDUSTRY ACTIVITY                                           II-61
      iCAD Expands Existing Partnership with Volpara Solutions          II-61
      Salient Imaging Takes Over Medipattern                            II-61
      Real Time Tomography Inks Licensing Agreement with im3D           II-61
      iCAD and Invivo Ink Agreement                                     II-61
      Planmed and Three Palm Software Ink Partnership Agreement         II-61
      Sectra Signs Agreement with Merge Healthcare                      II-61

  9. FOCUS ON SELECT PLAYERS                                            II-62
      EDDA Technology, Inc. (US)                                        II-62
      Hologic, Inc. (US)                                                II-62
      iCAD, Inc. (US)                                                   II-63
      Invivo Corp. (US)                                                 II-65
      Merge Healthcare, Inc. (US)                                       II-65
      Riverain Technologies (US)                                        II-66
      Salient Imaging, Inc. (US)                                        II-67
      Siemens Healthcare (Germany)                                      II-67
      VuCOMP Inc. (US)                                                  II-68


 III. COMPETITIVE LANDSCAPE

     Total Companies Profiled: 29 (including Divisions/Subsidiaries - 31)

     The United States (21)
     Japan (1)
     Europe (8)
     - Germany (2)
     - Italy (1)
     - Spain (1)
     - Rest of Europe (4)
     Asia-Pacific (Excluding Japan) (1)
Additional Information:
This report is offered in PDF format via e-mail. Once downloaded, the PDF can’t be copied to another computer. The user is permitted to print one full copy of the report. Extra copies or licenses may be purchased at 10% of the list price.
Date of Publication:
Feb 25, 2015
File Format:
PDF via E-mail
Number of Pages:
115 Pages
Type the characters you see in the picture above.